Patient Capital Management, LLC

BALTIMORE, MD · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 12, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$2.98B2026 Q3+ $167.2M options (notional, not included)
Positions41
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.50.4%

What Changed This Quarter?

4 new stocks bought: Meta Platforms (4.0%), AVGO (2.7%), IDRV (0.0%) +13 positions fully exited: ILMN, PLAY, SPY Biggest add: QXO +53.2% in shares Biggest trim: JD -89.9% in shares

Read the 2026-Q2 quarterly report · 13F Filing Calendar

🔔 Tell me when this fund files a new 13F

No account needed: in your inbox the morning it is published.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.